Claudia Stefanutti

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Marina Cuchel, Emma A. Meagher, Hendrik du Toit Theron et al. · The Lancet · 2012 · 728 citations · Full text

Metabolic Syndrome, Lipid Disorder, Homozygous Familial Hypercholesterolaemia +7

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

Raúl D. Santos, Andrea Ruzza, G. Kees Hovingh et al. · New England Journal of Medicine · 2020 · 180 citations · Full text

The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)

Fjolla Zhubi Bakija, Gani Bajraktari, Ibadete Bytyçi et al. · Clinical Nutrition · 2020 · 130 citations · Full text

Therapeutic Plasma Exchange in Patients With Severe Hypertriglyceridemia: A Multicenter Study

Claudia Stefanutti, S. Di Giacomo, A. Vivenzio et al. · Artificial Organs · 2009 · 84 citations

The effect of an apolipoprotein A-I–containing high-density lipoprotein–mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia

G. Kees Hovingh, Loek P. Smits, Claudia Stefanutti et al. · American Heart Journal · 2015 · 66 citations

Vascular Disease, Homozygous Familial Hypercholesterolemia, Cardiovascular Disease +9